This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Du Pen, S. L. Articles by Syrjala, K. Search for Related Content PubMed PubMed Citation Articles by Du Pen, S. L. Articles by Syrjala, K.

Implementing Guidelines for Cancer Pain Management: Results of a Randomized Controlled Clinical Trial

From the Swedish Medical Center, Seattle, WA.

Address reprint requests to Stuart Du Pen, MD, 1221 Madison, No. 410, Seattle, WA 98104; Email stuart.dupen{at}painconsult.com

PURPOSE: Pain and symptom management is an integral part of the clinical practice of oncology. A number of guidelines have been developed to assist the clinician in optimizing comfort care. We implemented clinical guidelines for cancer pain management in the community setting and evaluated whether these guidelines improved care.

PATIENTS AND METHODS: Eighty-one cancer patients, aged 37 to 76 years, were enrolled onto a prospective, longitudinal, randomized controlled study from the outpatient clinic settings of 26 western Washington–area medical oncologists. A multilevel treatment algorithm based on the Agency for Health Care Policy and Research Guidelines for Cancer Pain Management was compared with standard-practice (control) pain and symptom management therapies used by community oncologists. The primary outcome of interest was pain (Brief Pain Inventory); secondary outcomes of interest were all other symptoms (Memorial Symptom Assessment Scale) and quality of life (Functional Assessment of Cancer Therapy Scale).

RESULTS: Patients randomized to the pain algorithm group achieved a statistically significant reduction in usual pain intensity, measured as slope scores, when compared with standard community practice (P < .02). Concurrent chemotherapy and patient adherence to treatment were significant mediators of worst pain. There were no significant differences in other symptoms or quality of life between the two treatment groups.

CONCLUSION: This guideline implementation study supports the use of algorithmic decision making in the management of cancer pain. These findings suggest that comprehensive pain assessment and evidence-based analgesic decision-making processes do enhance usual pain outcomes.

The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or the William Gates Foundation.

This article has been cited by other articles:

				J. S. Kutner, M. C. Smith, L. Corbin, L. Hemphill, K. Benton, B. K. Mellis, B. Beaty, S. Felton, T. E. Yamashita, L. L. Bryant, et al. Massage Therapy versus Simple Touch to Improve Pain and Mood in Patients with Advanced Cancer: A Randomized Trial Ann Intern Med, September 16, 2008; 149(6): 369 - 379. [Abstract] [Full Text] [PDF]

				S. M. Dy, S. M. Asch, A. Naeim, H. Sanati, A. Walling, and K. A. Lorenz Evidence-Based Standards for Cancer Pain Management J. Clin. Oncol., August 10, 2008; 26(23): 3879 - 3885. [Abstract] [Full Text] [PDF]

				P. Hoskin Opioids in context: relieving the pain of cancer. The role of comprehensive cancer management Palliative Medicine, June 1, 2008; 22(4): 303 - 309. [Abstract] [PDF]

				G. H. Guyatt, P. J. Karanicolas, and R. Kunz Rebuttal From Dr. Guyatt et al Chest, May 1, 2008; 133(5): 1074 - 1075. [Full Text] [PDF]

				D. C Currow, A. P Abernethy, T. M Shelby-James, and P. A Phillips The impact of conducting a regional palliative care clinical study Palliative Medicine, December 1, 2006; 20(8): 735 - 743. [Abstract] [PDF]

				K. A. Lorenz, J. Lynn, S. Dy, A. Wilkinson, R. A. Mularski, L. R. Shugarman, R. Hughes, S. M. Asch, C. Rolon, A. Rastegar, et al. Quality Measures for Symptoms and Advance Care Planning in Cancer: A Systematic Review J. Clin. Oncol., October 20, 2006; 24(30): 4933 - 4938. [Abstract] [Full Text] [PDF]

				D. J. Weschules, T. Maxwell, J. Reifsnyder, and C. H. Knowlton Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting? American Journal of Hospice and Palliative Medicine, March 1, 2006; 23(2): 135 - 149. [Abstract] [PDF]

				C. S. Cleeland, R. K. Portenoy, M. Rue, T. R. Mendoza, E. Weller, R. Payne, J. Kirshner, J. N. Atkins, P. A. Johnson, and A. Marcus Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group Ann. Onc., June 1, 2005; 16(6): 972 - 980. [Abstract] [Full Text] [PDF]

				T. J. Smith, P. J. Coyne, P. S. Staats, T. Deer, L. J. Stearns, R. L. Rauck, R. L. Boortz-Marx, E. Buchser, E. Catala, D. A. Bryce, et al. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM) Ann. Onc., May 1, 2005; 16(5): 825 - 833. [Abstract] [Full Text] [PDF]

				K. O. Anderson, T. R. Mendoza, R. Payne, V. Valero, G. R. Palos, A. Nazario, S. P. Richman, J. Hurley, I. Gning, G. R. Lynch, et al. Pain Education for Underserved Minority Cancer Patients: A Randomized Controlled Trial J. Clin. Oncol., December 15, 2004; 22(24): 4918 - 4925. [Abstract] [Full Text] [PDF]

				N. Wells, B. Murphy, S. Douglas, and N. Yelton Establishing the safety and efficacy of an opioid titration protocol American Journal of Hospice and Palliative Medicine, September 1, 2004; 21(5): 373 - 380. [Abstract] [PDF]

				D. Oxenham, R. Duncan, and M. Fischbacher Cancer pain management in Lanarkshire: a communitybased audit Palliative Medicine, December 1, 2003; 17(8): 708 - 713. [Abstract] [PDF]

				T. J. Smith, P. Staats, and P. J. Coyne In reply: J. Clin. Oncol., July 15, 2003; 21(14): 2802 - 2803. [Full Text] [PDF]

				T. J. Smith, P. S. Staats, T. Deer, L. J. Stearns, R. L. Rauck, R. L. Boortz-Marx, E. Buchser, E. Catala, D. A. Bryce, P. J. Coyne, et al. Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival J. Clin. Oncol., October 1, 2002; 20(19): 4040 - 4049. [Abstract] [Full Text] [PDF]

				C. Miaskowski, M. J. Dodd, C. West, S. M. Paul, D. Tripathy, P. Koo, and K. Schumacher Lack of Adherence With the Analgesic Regimen: A Significant Barrier to Effective Cancer Pain Management J. Clin. Oncol., December 1, 2001; 19(23): 4275 - 4279. [Abstract] [Full Text]

				T. J. Smith and B. E. Hillner Ensuring Quality Cancer Care by the Use of Clinical Practice Guidelines and Critical Pathways J. Clin. Oncol., June 1, 2001; 19(11): 2886 - 2897. [Abstract] [Full Text] [PDF]

				D. Casarett and J. L. Abrahm Patients With Cancer Referred to Hospice Versus a Bridge Program: Patient Characteristics, Needs for Care, and Survival J. Clin. Oncol., April 1, 2001; 19(7): 2057 - 2063. [Abstract] [Full Text] [PDF]

				J. Lynn Serving Patients Who May Die Soon and Their Families: The Role of Hospice and Other Services JAMA, February 21, 2001; 285(7): 925 - 932. [Abstract] [Full Text] [PDF]

				R. S. Morrison, A. L. Siu, R. M. Leipzig, C. K. Cassel, and D. E. Meier The Hard Task of Improving the Quality of Care at the End of Life Arch Intern Med, March 27, 2000; 160(6): 743 - 747. [Full Text] [PDF]